Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/30/1998 | WO1998058672A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
12/30/1998 | WO1998058671A1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
12/30/1998 | WO1998058669A2 Cd154 blockade therapy for pancreatic islet tissue transplantation |
12/30/1998 | EP0887416A2 Human AFC1 |
12/30/1998 | EP0887415A2 Human RCE1 |
12/30/1998 | EP0887414A2 Human serine proteases HGBAB90 |
12/30/1998 | EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae |
12/30/1998 | EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides |
12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
12/30/1998 | EP0886651A1 Persephin and related growth factors |
12/30/1998 | EP0886646A1 Novel compounds |
12/30/1998 | EP0886644A1 Long wavelength engineered fluorescent proteins |
12/30/1998 | EP0886525A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b) |
12/30/1998 | EP0750637B1 Dna encoding cai resistance proteins and uses thereof |
12/30/1998 | EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines |
12/30/1998 | EP0633945B1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
12/30/1998 | EP0584273B1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
12/30/1998 | EP0584175B1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
12/30/1998 | EP0553244B1 Targeted immunostimulation with bispecific reagents |
12/30/1998 | EP0544805B1 Hormone detection methods |
12/30/1998 | EP0539522B1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
12/30/1998 | EP0463059B1 Allergenic proteins from ragweed and uses therefor |
12/30/1998 | CN1203603A Therapeutic compounds comprised of anti-FC receptor antibodies |
12/30/1998 | CN1203105A Process for preparing medicine for curing intractable psoriasis |
12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
12/30/1998 | CA2295200A1 Receptor kinase, bin1 |
12/30/1998 | CA2294651A1 Surface exposed proteins from chlamydia pneumoniae |
12/30/1998 | CA2294646A1 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
12/30/1998 | CA2294257A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
12/30/1998 | CA2294154A1 Cd154 blockade therapy for pancreatic islet tissue transplantation |
12/30/1998 | CA2294138A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
12/30/1998 | CA2293661A1 Reagents and methods useful for detecting diseases of the breast |
12/30/1998 | CA2292415A1 B7-binding molecules for treating immune diseases |
12/29/1998 | US5854416 Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor |
12/29/1998 | US5854415 Methods for the diagnosis of glaucoma |
12/29/1998 | US5854411 Human chloride channel |
12/29/1998 | US5854402 Antibodies against streptococcus |
12/29/1998 | US5854401 Determination of endometrial receptivity toward embryo implantation |
12/29/1998 | US5854400 Monoclonal antibodies which neutralize HIV-1 infection |
12/29/1998 | US5854395 Cloned borrelia burgdorferi virulence protein |
12/29/1998 | US5854392 β APP-C100 receptor |
12/29/1998 | US5854220 Glial mitogenic factors, their preparation and use |
12/29/1998 | US5854071 OP-3- induced morphongenesis |
12/29/1998 | US5854070 Murine and humanizer 23F2G antibodies and cell lines expressing said antibodies |
12/29/1998 | US5854069 GD2 anti-idiotypic antibodies and uses thereof |
12/29/1998 | US5854044 Recombinant pseudomonas exotoxin with increased activity |
12/29/1998 | US5854043 MEKK-related signal transduction kinases |
12/29/1998 | US5854027 Process for improving the stability of antibodies |
12/29/1998 | US5854022 Polynucleotides encoding a CD53-like transmembrane protein |
12/29/1998 | US5854020 TCSTS polynucleotides |
12/29/1998 | US5854016 Creba Isoform |
12/29/1998 | US5854007 Process for producing GM1 specific antibodies |
12/29/1998 | US5854006 Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof |
12/29/1998 | US5854001 Hepatitis C virus fusion proteins |
12/29/1998 | US5853999 Methods of screening for agents that inhibit interaction between MHC class I antigens and a cell surface receptor |
12/29/1998 | US5853997 Human protein phosphatase |
12/29/1998 | US5853987 Decorin binding protein compositions and methods of use |
12/29/1998 | US5853737 Method for inducing a CD1-restricted immune response |
12/29/1998 | US5853735 Avirulent anti-rabies vaccine |
12/29/1998 | US5853723 Targeting of peg antibody conjugates to islet cells |
12/29/1998 | US5853722 Use of C5-specific antibodies for reducing immune and hemostatic dysfunctions during extracorporeal circulation |
12/29/1998 | US5853721 Antibody to interleukin-12 receptor |
12/29/1998 | US5853697 Methods of treating established colitis using antibodies against IL-12 |
12/29/1998 | CA2150265C Activation of p53 protein |
12/29/1998 | CA2148689C Treatment of infertility and enhancement of fertilization capacity in mammalian males |
12/29/1998 | CA2130995C Method for treating macrophage pathogen infections |
12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
12/29/1998 | CA2065493C Monoclonal antibodies for measuring okadaic acid |
12/29/1998 | CA1340296C Cell growth regulatory factor |
12/29/1998 | CA1340295C Human somatomedin carrier protein subunits and process for procucing them |
12/29/1998 | CA1340289C Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies |
12/26/1998 | CA2235778A1 Novel glmu |
12/24/1998 | DE19736198C1 Protease related protein |
12/24/1998 | DE19725847A1 Antikörper gegen FLIP-Protein Antibodies against FLIP protein |
12/24/1998 | DE19725186A1 Herz- und Skelettmuskel-spezifische Nukleinsäure, ihre Herstellung und Verwendung Heart and skeletal muscle-specific nucleic acid, their preparation and use |
12/24/1998 | CA2234418A1 Human afc1 |
12/24/1998 | CA2234402A1 Human rce1 |
12/23/1998 | WO1998058066A1 New human lysophospholipase |
12/23/1998 | WO1998058062A1 Apo-2DcR |
12/23/1998 | WO1998058059A1 Lag-3 splice variants |
12/23/1998 | WO1998058054A1 Stat5-specific and regulatory protease |
12/23/1998 | WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
12/23/1998 | WO1998057993A1 Secretory immunoglobulin produced by single cells and methods for making and using same |
12/23/1998 | WO1998057992A2 Anti-flip protein antibodies |
12/23/1998 | WO1998057990A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity |
12/23/1998 | WO1998057989A1 Heregulin-like factor |
12/23/1998 | WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate |
12/23/1998 | WO1998057986A2 Human preprotachykinin b |
12/23/1998 | WO1998057984A2 Torsin, torsin genes, and methods of use |
12/23/1998 | WO1998057983A2 Mammalian neuro-growth factor like protein |
12/23/1998 | WO1998057982A2 Aib1, a steroid receptor co-activator |
12/23/1998 | WO1998057672A2 Process for reducing the concentration of viral and molecular pathogens in a biological material |
12/23/1998 | WO1998057661A1 Therapeutic composition and method of treatment |
12/23/1998 | WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
12/23/1998 | WO1998057621A1 Angiogenic modulation by notch signal transduction |
12/23/1998 | WO1998042830A3 Noey2 gene compositions and methods of use |
12/23/1998 | EP0886142A1 Method for detecting anti-gadii antibody and method for diagnosing cancer using said detection method |
12/23/1998 | EP0885967A2 Chaperone expression plasmids |
12/23/1998 | EP0885966A2 Novel compouds |